SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - PHARMACYTE BIOTECH INC ownership

PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 23 filers reported holding PHARMACYTE BIOTECH INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q1 2022$80,000
-28.6%
34,805
-22.6%
0.00%
-33.3%
Q4 2021$112,000
-29.1%
44,944
-9.6%
0.00%0.0%
Q3 2021$158,00049,7000.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,217,828$3,045,0000.44%
Ayrton Capital LLC 153,130$383,0000.36%
Shay Capital LLC 662,337$1,656,0000.27%
EQUITEC PROPRIETARY MARKETS, LLC 258,694$647,0000.09%
Anson Funds Management LP 193,400$484,0000.05%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 44,944$112,0000.00%
Jump Financial, LLC 10,300$26,0000.00%
Schonfeld Strategic Advisors LLC 30,400$76,0000.00%
Aspire Private Capital, LLC 800$2,0000.00%
OSAIC HOLDINGS, INC. 1,763$5,0000.00%
View complete list of PHARMACYTE BIOTECH INC shareholders